This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Womble Bond Dickinson

| less than a minute read

Mary Bourke, Julie Meigs & Dana Severance to Discuss Impact of In Re Cellect on Patents at Consero IP Life Sciences Forum

Womble Bond Dickinson Partners Mary Bourke, Julie Meigs, Ph.D., and Dana Severance will speak at Consero’s IP Life Sciences Forum.

Their presentation titled “ODP to RIP – How In Re Cellect May Reduce the Life of Your Patent” will address the following topics:

  • Is PTA an “unjustified” term adjustment or an “inappropriate” one? Who gets to decide?
  • How does In Re Cellect impact my filing and prosecution strategy? (How to avoid and respond to ODP rejections, genus/species filing strategy, and patent family management)
  • My existing portfolio includes patents at risk in view of In Re Cellect – what should I do?
  • Should I swap PTA for PTE? Should I be drafting my PTE applications differently?
  • How can I recover PTE that was foreclosed by PTA?

The Consero IP Life Sciences Forum takes place Dec. 4-6 in Westlake Village, Calif.

Tags

life sciences, patent litigation, intellectual property litigation, intellectual property, ip licensing and transactions, patents - chemical pharma biotech